Myositis
- Interventions May Improve Dysphagia in Patients With Inclusion Body Myositis
- Rituximab Associated With Glucocorticoid-Free Remission in Polymyalgia Rheumatica
- Cyclophosphamide Improves Functional Outcomes in Inflammatory Myopathy-Related ILD
- Sarilumab Approved for Polymyalgia Rheumatica
- Zilucoplan May Not Be Effective for Necrotizing Myopathy
- Dermatomyositis Protective for Some Aspects of COVID-19
- EULAR/ACR Criteria Misses 30% of Patients With Anti-MDA5-Related IIM
- Antisense Oligonucleotide Fast-Tracked for Certain Myopathies
- Incidence, Prevalence, and Mortality of DM in Adults
- Novel GLP-1 Receptor Agonist Designated Orphan Drug for Polymyositis
- Clinical, Histopathologic Features of DM and MDA5 Autoantibody Seropositivity
- IGIV (Human) 10% Approved for Adult DM
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
